Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
AC Immune (ACIU) had Cash Flow from Investing Activities of $-119.60M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$31.02M |
|
$-57.84M |
|
-- |
|
$31.02M |
|
$90.52M |
|
$-59.50M |
|
$1.66M |
|
$-57.83M |
|
$-57.83M |
|
$-57.84M |
|
$-57.84M |
|
$-57.84M |
|
$-57.84M |
|
$-59.50M |
|
$-57.04M |
|
99.69M |
|
99.69M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$195.37M |
|
$3.01M |
|
$66.93M |
|
$262.29M |
|
$114.54M |
|
-- |
|
$20.22M |
|
$134.77M |
|
$127.53M |
|
$70.26M |
|
$127.53M |
|
100.41M |
|
| Cash Flow Statement Financials | |
$74.79M |
|
|
Cash Flow from Investing Activities |
$-119.60M |
$-1.27M |
|
$89.16M |
|
$41.20M |
|
$-47.96M |
|
$6.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-191.80% |
|
-191.80% |
|
-183.88% |
|
-186.43% |
|
-186.44% |
|
$74.14M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
24.74 |
|
14.76 |
|
-45.35% |
|
-82.32% |
|
-22.05% |
|
-45.35% |
|
$1.27 |
|
$0.74 |
|
$0.75 |
|